Massimo Boemi

5.3k total citations · 1 hit paper
71 papers, 2.4k citations indexed

About

Massimo Boemi is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Massimo Boemi has authored 71 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Endocrinology, Diabetes and Metabolism, 21 papers in Surgery and 13 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Massimo Boemi's work include Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Treatment and Management (13 papers) and Diabetes Management and Research (12 papers). Massimo Boemi is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (15 papers), Diabetes Treatment and Management (13 papers) and Diabetes Management and Research (12 papers). Massimo Boemi collaborates with scholars based in Italy, Switzerland and Spain. Massimo Boemi's co-authors include Roberto Testa, Antonio Ceriello, Katherine Esposito, Michael A. Ihnat, Dario Giugliano, Jessica E. Thorpe, Ludovica Piconi, P. Fumelli, Richard W. James and C. Sirolla and has published in prestigious journals such as PLoS ONE, Diabetes Care and Diabetes.

In The Last Decade

Massimo Boemi

70 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oscillating Glucose Is More Deleterious to Endothelial Function and Oxidative Stress Than Mean Glucose in Normal and Type 2 Diabetic Patients

2008 987 citations Antonio Ceriello, Roberto Testa et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Massimo Boemi Italy	23	1.1k	469	417	405	368	71	2.4k
Maria Luiza Caramori United States	16	852 0.8×	555 1.2×	368 0.9×	395 1.0×	264 0.7×	32	2.7k
Sandra Pinho Silveiro Brazil	24	965 0.9×	443 0.9×	515 1.2×	412 1.0×	251 0.7×	91	3.0k
Peter Winocour United Kingdom	29	1.3k 1.2×	509 1.1×	693 1.7×	467 1.2×	309 0.8×	118	3.2k
S. Halimi France	27	1.4k 1.3×	574 1.2×	487 1.2×	445 1.1×	334 0.9×	172	2.8k
Themis Zelmanovitz Brazil	18	781 0.7×	376 0.8×	260 0.6×	388 1.0×	443 1.2×	35	2.3k
Ilaria Ferrari Italy	30	932 0.9×	752 1.6×	298 0.7×	323 0.8×	288 0.8×	79	2.1k
Radica Z. Alicic United States	19	1.3k 1.2×	809 1.7×	511 1.2×	402 1.0×	280 0.8×	48	3.2k
Peter Fasching Austria	24	664 0.6×	306 0.7×	380 0.9×	348 0.9×	413 1.1×	89	2.0k
Young Seol Kim South Korea	29	725 0.7×	568 1.2×	361 0.9×	217 0.5×	487 1.3×	106	2.4k
Sang Youb Han South Korea	33	718 0.7×	982 2.1×	541 1.3×	545 1.3×	367 1.0×	115	3.3k

Countries citing papers authored by Massimo Boemi

Since Specialization

Citations

This map shows the geographic impact of Massimo Boemi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Boemi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Boemi more than expected).

Fields of papers citing papers by Massimo Boemi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Boemi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Boemi. The network helps show where Massimo Boemi may publish in the future.

Co-authorship network of co-authors of Massimo Boemi

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Boemi. A scholar is included among the top collaborators of Massimo Boemi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Boemi. Massimo Boemi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Simioni, Natalino, Cesare Berra, Massimo Boemi, et al.. (2018). Predictors of treatment response to liraglutide in type 2 diabetes in a real-world setting. Acta Diabetologica. 55(6). 557–568. 18 indexed citations

Bonfigli, Anna Rita, Massimo Boemi, R. Festa, et al.. (2016). Randomized, double-blind, placebo-controlled trial to evaluate the effect of Helicobacter pylori eradication on glucose homeostasis in type 2 diabetic patients. Nutrition Metabolism and Cardiovascular Diseases. 26(10). 893–898. 27 indexed citations

Bonfigli, Anna Rita, Liana Spazzafumo, Francesco Prattichizzo, et al.. (2016). Leukocyte telomere length and mortality risk in patients with type 2 diabetes. Oncotarget. 7(32). 50835–50844. 49 indexed citations

Bonfigli, Anna Rita, C. Sirolla, Roberto Testa, et al.. (2012). The p53 codon 72 (Arg72Pro) polymorphism is associated with the degree of insulin resistance in type 2 diabetic subjects: a cross-sectional study. Acta Diabetologica. 50(3). 429–436. 28 indexed citations

Boemi, Massimo, et al.. (2011). Intensifying existing premix therapy (BIAsp 30) with BIAsp 50 and BIAsp 70: A consensus statement. Indian Journal of Endocrinology and Metabolism. 15(3). 152–160. 5 indexed citations

Burattini, Roberto, Micaela Morettini, Francesco Di Nardo, & Massimo Boemi. (2011). Dynamics of insulin action in hypertension: assessment from minimal model interpretation of intravenous glucose tolerance test data. Medical & Biological Engineering & Computing. 49(7). 831–841. 5 indexed citations

Giorda, Carlo, et al.. (2010). The IMPROVE study--a multinational, multicentre, observational study in type 2 diabetes: results from the Italian cohort.. PubMed. 81(2). 115–24. 4 indexed citations

Nardo, Francesco Di, Massimo Boemi, & Roberto Burattini. (2009). Assessment of hepatic insulin degradation, in normoglycemic hypertensive patients, by minimal modelling of standard intravenous glucose tolerance test data. Computer Methods and Programs in Biomedicine. 97(2). 189–198. 7 indexed citations

Vaccaro, Olga, Massimo Boemi, Franco Cavalot, et al.. (2008). The clinical reality of guidelines for primary prevention of cardiovascular disease in type 2 diabetes in Italy. Atherosclerosis. 198(2). 396–402. 36 indexed citations

10.

Rivellese, A.A., Massimo Boemi, Franco Cavalot, et al.. (2007). Dietary habits in type II diabetes mellitus: how is adherence to dietary recommendations?. European Journal of Clinical Nutrition. 62(5). 660–664. 63 indexed citations

11.

Testa, Roberto, Anna Rita Bonfigli, C. Sirolla, et al.. (2007). C-reactive protein is directly related to plasminogen activator inhibitor type 1 (PAI-1) levels in diabetic subjects with the 4G allele at position −675 of the PAI-1 gene. Nutrition Metabolism and Cardiovascular Diseases. 18(3). 220–226. 10 indexed citations

12.

Nardo, Francesco Di, et al.. (2006). Insulin secretion rate and ß-cell sensitivity from oral glucose tolerance test in normotensive and normoglycemic humans. PubMed. 280. 449–450. 2 indexed citations

13.

Moretti, Simona, Antonio Domenico Procopio, Massimo Boemi, & Alfonso Catalano. (2006). Neuronal Semaphorins Regulate a Primary Immune Response. Current Neurovascular Research. 3(4). 295–305. 18 indexed citations

14.

Boemi, Massimo, C. Sirolla, Roberto Testa, et al.. (2003). Apolipoprotein E polymorphisms and mortality in Italian Type 2 diabetic patients. European Journal of Clinical Investigation. 33(4). 296–300. 6 indexed citations

15.

Boemi, Massimo, et al.. (2000). One- and two-compartment minimal models detect similar alterations of glucose metabolism indexes in hypertension. Metabolism. 49(12). 1529–1536. 6 indexed citations

16.

Fumelli, P., et al.. (2000). Influence of body mass on glycemic control in a type 2 diabetic population: a 3-year follow-up. Archives of Gerontology and Geriatrics. 30(1). 1–5. 3 indexed citations

17.

Giansanti, R., et al.. (1999). Coronary heart disease, type 2 diabetes mellitus and cardiovascular disease risk factors: a study on a middle-aged and elderly population. Archives of Gerontology and Geriatrics. 29(2). 175–181. 17 indexed citations

18.

Fumelli, P., et al.. (1996). Diabetes mellitus and chronic heart failure. Archives of Gerontology and Geriatrics. 23(3). 277–281. 30 indexed citations

19.

James, Richard W., Massimo Boemi, C. Sirolla, et al.. (1995). Lipoprotein (a) and vascular disease in diabetic patients. Diabetologia. 38(6). 711–714. 32 indexed citations

20.

Tranquilli, Andrea Luigi, G. G. Garzetti, G. De Tommaso, et al.. (1992). Nifedipine treatment in preeclampsia reverts the increased erythrocyte aggregation to normal. American Journal of Obstetrics and Gynecology. 167(4). 942–945. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact